當(dāng)前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ3 期刊介紹(非官網(wǎng))

Coronary Artery DiseaseSCIE

國際簡稱：CORONARY ARTERY DIS 參考譯名：冠狀動脈疾病

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q3
JCR分區(qū)
Q3

基本信息：: ISSN：0954-6928; E-ISSN：1473-5830; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Lippincott Williams and Wilkins Ltd.; 出版語言：English; 出版周期：Bimonthly; 出版年份：1990; 研究方向：醫(yī)學(xué)-外周血管病

評價信息：: 影響因子：1.5; H-index：58; CiteScore指數(shù)：2.5; SJR指數(shù)：0.384; SNIP指數(shù)：0.472

發(fā)文數(shù)據(jù)：: Gold OA文章占比：10.47%; 研究類文章占比：88.73%; 年發(fā)文量：71; 自引率：0; 開源占比：0.0657; 出版撤稿占比：0; 出版國人文章占比：0; OA被引用占比：0.0294...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Coronary Artery Disease期刊介紹

Coronary Artery Disease welcomes reports of original research with a clinical emphasis, including observational studies, clinical trials, translational research, novel imaging, pharmacology and interventional approaches as well as advances in laboratory research that contribute to the understanding of coronary artery disease. Each issue of Coronary Artery Disease is divided into four areas of focus: Original Research articles, Review in Depth articles by leading experts in the field, Editorials and Images in Coronary Artery Disease. The Editorials will comment on selected original research published in each issue of Coronary Artery Disease, as well as highlight controversies in coronary artery disease understanding and management.

Submitted artcles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and? peer-review by the editors and those invited to do so from a reviewer pool.

期刊簡介Coronary Artery Disease期刊介紹

《Coronary Artery Disease》自1990出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間：較慢,6-12周
醫(yī)學(xué)
CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Coronary Artery Disease Cite Score數(shù)據(jù)

CiteScore：2.5
SJR：0.384
SNIP：0.472

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Cardiology and Cardiovascular Medicine	Q3	225 / 387	41%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻(xiàn)計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Coronary Artery Disease 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Coronary Artery Disease JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	145 / 220	34.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	137 / 220	37.95%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

本刊中國學(xué)者近年發(fā)表論文

1、Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors
Author: Guo, Xuantong; Ma, Lihong

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 1, pp. 66-77. DOI: 10.1097/MCA.0000000000001198
2、Obstructive sleep apnea and cardiovascular events in acute coronary syndrome: a meta-analysis
Author: Tong, Jiangtao; Yu, Qian; Li, Yuan; Du, Jianbo; Qiu, Jian

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 3, pp. 177-184. DOI: 10.1097/MCA.0000000000001207
3、Association between monocyte to high-density lipoprotein ratio and coronary heart disease in US adults in the National Health and Nutrition Examination Surveys 2009-2018
Author: Yan, Shaoyi; Sha, Shuo; Wang, Di; Li, Senjie; Jia, Yongping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 111-118. DOI: 10.1097/MCA.0000000000001208
4、The relationship between hyperhomocysteinemia and total coronary artery occlusion: a cross-sectional study from Southwest China
Author: Xiao, Kaiyong; Chen, Yuxiong; Xiao, Lian; Sun, Hua; He, Zhongwei; Huang, Guan; Chen, Lvhong; Xv, Lei; Peng, Ling; Li, Juan; Xv, Yuling; Wang, Jianping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 138-145. DOI: 10.1097/MCA.0000000000001217
5、Comparison between radial and femoral access for percutaneous coronary intervention in left main coronary artery disease: a meta-analysis of nonrandomized trials.
Author: Ye Y¹, Zeng Y.

Journal: Coron Artery Dis. 2019 Mar;30(2):79-86. doi: 10.1097/MCA.0000000000000685.
6、Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
Author: Lin LH¹, Liu H^2,¹, Tu Y², Yang Y², Wang B^2,¹, Wang FM², Wu M², Pan MM^2,¹, Tang RN^2,¹, Ma KL^2,¹, Zhang XL^2,¹, Liu BC^2,¹.

Journal: Coron Artery Dis. 2019 Mar;30(2):137-142. doi: 10.1097/MCA.0000000000000692.
7、Serum apelin predicts spontaneous reperfusion of infarct-related artery in patients with ST-segment elevation myocardial infarction.
Author: Ying Z¹, Jiansong Y², Yong W¹, Shubin Q².

Journal: Coron Artery Dis. 2019 Mar;30(2):103-108. doi: 10.1097/MCA.0000000000000702.
8、Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Author: Wang X¹, Li X, Wu H, Li R, Liu H, Wang L, Bai S, Zhang L, Chen T, Liu J, Li Q, Du R.

Journal: Coron Artery Dis. 2019 Jan 5. doi: 10.1097/MCA.0000000000000707. [Epub ahead of print]